h292 human lung cancer cell line nci h292 (ATCC)
Structured Review
H292 Human Lung Cancer Cell Line Nci H292, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 159 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+carcinoma+cell+line+h292/NCI-H292%3B+Lung+Carcinoma%3B+Human/us11939385-1105-0-7
Average 95 stars, based on 159 article reviews
Images
Related Articles
other:Article Title: Human Serum Amyloid A3 (SAA3) Protein, Expressed as a Fusion Protein with SAA2, Binds the Oxidized Low Density Lipoprotein Receptor Article Snippet: HUVEC, human lung carcinoma cell line H292, and Article Title: Irradiation conditioning of adjuvanted, autologous cancer cell membrane nanoparticle vaccines Article Snippet: Cancer vaccines systems based on autologous cancer cell membrane fragments (CMs) have attracted attention due to broad antigen coverage, however, the lack of immunogenicity of conventional cancer CMs bring the limitations of application.. Here, the next-generation nanovaccines is constructed using irradiated cancer cell membrane (RM) coated on a polylactic-co-glycolic acid (PLGA) nanoscale delivery system loaded with a TLR-7 agonist (R837) to generate the RP@RMs vaccine with prophylactic and therapeutic anti-cancer properties.. Irradiation of cell results in enhanced expression of major histocompatibility complex I (MHCI) on the cell membrane. |
